Insider Trading disclosures for Decibel Therapeutics Inc

The latest disclosure was made by Laurence E. Reid in Decibel Therapeutics Inc where a trade of 72,000 Stock Options (right to buy) done was reported to US exchanges on March 16, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Laurence E. Reid	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	72,000	72,000	-		-	Stock Options (right to buy)
Laurence E. Reid	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Mar 2023	195,000	220,849	-		0	Common Stock
Anna Trask	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	45,000	45,000	-		-	Stock Options (right to buy)
Anna Trask	Chief People Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	105,000	106,864	-		0	Common Stock
John Lee	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	45,000	45,000	-		-	Stock Options (right to buy)
John Lee	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	120,000	147,144	-		0	Common Stock
Peter A. Thompson	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	10,000	10,000	-		-	Stock Option (right to buy)
Neil Exter	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	10,000	10,000	-		-	Stock Option (right to buy)
Alison Cecily Finger	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	10,000	10,000	-		-	Stock Option (right to buy)
William H. Carson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	10,000	10,000	-		-	Stock Option (right to buy)
Saraswathy V. Nochur	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jun 2022	10,000	10,000	-		-	Stock Option (right to buy)
John Lee	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2022	52,500	52,500	-		-	Stock Options (right to buy)
Laurence E. Reid	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2022	187,500	187,500	-		-	Stock Options (right to buy)
Elisabeth Leiderman	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2022	52,500	52,500	-		-	Stock Options (right to buy)
Anna Trask	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2022	52,500	52,500	-		-	Stock Options (right to buy)
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 5.00 per share.	03 Jan 2022	1	2,241	-	5	5	Common Stock
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 5.03 per share.	03 Jan 2022	377	1,864	-	5.0	1,896	Common Stock
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 6.34 per share.	02 Dec 2021	378	2,242	-	6.3	2,395	Common Stock
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 6.37 per share.	02 Dec 2021	4,913	2,620	-	6.4	31,293	Common Stock
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 8.34 per share.	03 Nov 2021	378	7,533	-	8.3	3,152	Common Stock
Anna Trask	SEE REMARKS	Sale of securities on an exchange or to another person at price $ 8.31 per share.	02 Nov 2021	4,913	7,911	-	8.3	40,827	Common Stock
Anna Trask	See Remarks	Sale of securities on an exchange or to another person at price $ 7.55 per share.	14 Oct 2021	5,364	12,824	-	7.5	40,481	Common Stock
William H. Carson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jun 2021	20,000	20,000	-		-	Stock Option (right to buy)
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	289,603	0	-		-	Series D Preferred Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	218,568	218,568	-		-	Common Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	2,732,106	2,732,106	-		-	Common Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	327,852	327,852	-		-	Common Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	1,158,412	0	-		-	Series D Preferred Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	1,737,619	0	-		-	Series D Preferred Stock
Peter A. Thompson	Director, Ten Percent Owner		17 Feb 2021	14,480,162	0	-		-	Series D Preferred Stock
Peter A. Thompson	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 18.00 per share.	17 Feb 2021	555,566	883,418	-	18	10,000,188	Common Stock
Peter A. Thompson	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 18.00 per share.	17 Feb 2021	1,111,100	3,843,206	-	18	19,999,800	Common Stock
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	98,929	3,085,043	-		-	Common Stock
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	54,642	3,139,685	-		-	Common Stock
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	1,250,000	0	-		-	Series C Preferred Stock
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	45,638,882	0	-		-	Series A Preferred Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	3,125,000	0	-		-	Series C Preferred Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	7,119,852	0	-		-	Series A Preferred Stock
Matthew Foy	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 18.00 per share.	17 Feb 2021	150,000	1,183,663	-	18	2,700,000	Common Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	327,852	1,033,663	-		-	Common Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	247,324	705,811	-		-	Common Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	458,487	458,487	-		-	Common Stock
Matthew Foy	Director, Ten Percent Owner		17 Feb 2021	1,737,619	0	-		-	Series D Preferred Stock
Neil Exter	Director, Ten Percent Owner		17 Feb 2021	2,938,945	2,986,114	-		-	Common Stock
Matthew Foy	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)
Neil Exter	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2021	20,000	20,000	-		-	Stock Option(right to buy)
Christine A. Poon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)
Peter A. Thompson	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Feb 2021	20,000	20,000	-		-	Stock Option (right to buy)

Showing 1 to 48 of 48 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for Decibel Therapeutics Inc

The latest disclosure was made by Laurence E. Reid in Decibel Therapeutics Inc where a trade of 72,000 Stock Options (right to buy) done was reported to US exchanges on March 16, 2023.

Screeners based on Insider Trading and SAST parameters